Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Categorynews

Share buyback program – Ipsen reporting from 05 to 09 July 2021 – Detailed

May 23, 2023 Off By GlobeNewswire

This article or press release has no online content. Please download the associated documents for more information.  
Attachment

Share-buyback-program-Ipsen-reporting-from-05-to-09-July-2021-Detailled

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Related

Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
Innate Pharma to Participate in Upcoming Investor Conferences

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Cabbacis to Host Live Webinar to Discuss $7.5 Million Offering and its Better Smoking and Vaping Alternatives

January 14, 2026 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine
Go to mobile version